Overall, LMTK3, KAP1 and PP1α are co-expressed in the majority of breast cancers where they collaborate to repress tumour suppressor-like genes through the remodelling of chromatin, which promotes a more aggressive phenotype. This evidence concerns the gene LMTK3 and breast carcinoma.